Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis

Lignende værker

• The Application and Implications of Novel Deterministic Sensitivity Analysis Methods
  af: Vreman, Rick A., et al.
  Udgivet: (2020)
• Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs
  af: Vreman, Rick A., et al.
  Udgivet: (2018)
• Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
  af: Vreman, Rick A., et al.
  Udgivet: (2020)
• Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix
  af: Marcelien H. E. Callenbach, et al.
  Udgivet: (2025-10-01)
• Efficacy gap between phase II and subsequent phase III studies in oncology
  af: Vreman, Rick A., et al.
  Udgivet: (2020)